查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1527077

2024 年神經遺傳學測試全球市場報告

Neurogenetic Testing Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

神經遺傳學檢測市場規模預計在未來幾年將快速成長。 2028年，將以13.6%的複合年成長率成長至10.2億美元。預測期內的成長歸因於個人化醫療應用的擴大、慢性病數量的增加、醫院數量的增加、診斷實驗室數量的增加以及早期疾病檢測需求的增加。這段時期的主要趨勢包括技術進步、非侵入性檢測方法的更多採用、新產品開發、策略聯盟以及神經系統疾病新生物標記的出現。

神經系統疾病的增加預計將推動神經遺傳學檢測市場的成長。神經系統疾病包括影響神經系統的疾病，包括大腦、脊髓和神經。這些疾病是由遺傳素質、感染疾病、創傷、毒素、自體免疫反應、退化等引起的。神經遺傳學檢測在強化神經系統疾病的診斷、治療和管理方面發揮重要作用。透過提供對遺傳風險因素的個人化見解來指導治療決策並幫助患者和家屬做出明智的醫療選擇，改善患者護理和結果。例如，根據歐洲腦理事會 2022 年 4 月報告，全球有數百萬人患有 600 多種神經系統疾病和近 300 種精神疾病，其中包括 6500 萬人患有癲癇症。在歐洲，有 1,050 萬人患有失智症，預計到 2050 年將增加至 1,870 萬人。因此，神經系統疾病的日益普及預計將推動神經遺傳學檢測市場的成長。

癌症盛行率的上升預計也將推動神經遺傳學檢測市場的發展。癌症以不受控制的細胞分裂和組織破壞為特徵，是由肥胖流行、遺傳性基因異常以及乙型和丙型肝炎、 EB病毒（EBV）和人類乳突病毒（HPV）等病毒感染引起的。上升的原因包括：神經遺傳學檢測對於癌症管理至關重要，因為它有助於選擇最有效的治療方法、評估預後、識別高風險患者，並根據個體的基因譜和家族病史，這很重要。例如，美國臨床腫瘤學會在2024年5月宣布，估計2022年將確認2,000萬新癌症病例，2050年全球整體將確認3,500萬新病例，因這種疾病死亡的人數為預計將達到970萬人。因此，癌症盛行率的增加正在推動神經遺傳學檢測市場的成長。

目錄

第1章執行概述

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球神經遺傳學測試市場：促進因素與限制因素
    • 市場促進因素
    • 市場限制因素
  • 全球神經遺傳學測試市場表現：規模和成長，2018-2023
  • 全球神經遺傳學測試市場預測：規模和成長，2023-2028 年、2033 年

第6章 市場細分

  • 全球神經遺傳學測試市場：按類型、實際和預測分類，2018-2023、2023-2028、2033
  • 微陣列分析
  • 全EXOME定序 (WES)
  • 多重連接依賴性探針擴增 (MLPA)
  • 聚合酵素鏈鎖反應（PCR）測試
  • 其他
  • 全球神經遺傳學檢測市場：按疾病、表現和預測，2018-2023、2023-2028、2033
  • 罕見遺傳疾病
  • 癌症
  • 囊腫纖維化
  • 鐮狀貧血
  • Duchenne氏肌肉失養症
  • 地中海型貧血
  • 亨丁頓舞蹈症
  • X染色體脆折症候群
  • 其他
  • 全球神經遺傳學測試市場：按最終用戶、效能和預測，2018-2023、2023-2028、2033
  • 醫院
  • 專科診所
  • 研究所
  • 診斷實驗室

第 7 章 區域/國家分析

  • 全球神經遺傳學測試市場：按地區、績效和預測，2018-2023、2023-2028、2033
  • 全球神經遺傳學測試市場：按國家、績效和預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭格局及公司概況

  • 神經遺傳學檢測市場：競爭格局
  • 神經遺傳學測試市場：公司簡介
    • Thermo Fisher Scientific Inc.
    • Mayo Clinic
    • Roche Diagnostics Corporation
    • Laboratory Corporation
    • Quest Diagnostics Incorporated

第31章 其他重大及創新企業

  • Eurofins Scientific Inc.
  • Agilent Technologies Inc.
  • PerkinElmer Inc.
  • Illumina Inc.
  • Bio-Rad Laboratories Inc.
  • QIAGEN NV
  • Exact Sciences Corporation
  • Myriad Genetics Inc.
  • BioReference Laboratories Inc.
  • Connecticut Children's
  • Invitae Corp.
  • Ambry Genetics Corporation
  • Fulgent Genetics Inc.
  • Blueprint Genetics Inc.
  • GeneDx LLC

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章 未來展望與潛力分析

第36章附錄

簡介目錄
Product Code: r18682

Neurogenetic testing is a form of genetic testing that focuses on identifying genetic variations linked to neurological disorders or conditions impacting the nervous system. It aids in diagnosis, prediction, and management of neurological disorders, supports research, and helps develop personalized treatment strategies in neurology and genetics.

The main types of neurogenetic testing in the market include microarray analysis, whole-exome sequencing (WES), multiplex ligation-dependent probe amplification (MLPA), polymerase chain reaction (PCR) tests, and others. Microarray analysis is a technique in neurogenetic testing that simultaneously assesses the expression levels of thousands of genes. These tests are used for various diseases such as rare genetic disorders, cancer, cystic fibrosis, sickle cell anemia, Duchenne muscular dystrophy, thalassemia, Huntington's disease, fragile X syndrome, and others. They are utilized by hospitals, specialty clinics, research institutes, and diagnostics laboratories.

The neurogenetic testing market research report is one of a series of new reports from The Business Research Company that provides neurogenetic testing market statistics, including neurogenetic testing industry global market size, regional shares, competitors with a neurogenetic testing market share, detailed neurogenetic testing market segments, market trends, and opportunities, and any further data you may need to thrive in the neurogenetic testing industry. This neurogenetic testing research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The neurogenetic testing market size has grown rapidly in recent years. It will grow from $0.54 billion in 2023 to $0.61 billion in 2024 at a compound annual growth rate (CAGR) of 13.3%. The growth in the historic period can be attributed to an increased prevalence of neurological disease cases, increased research in the life science domain, the rising prevalence of Parkinson's disease, increased cases of cancer, and rising awareness among healthcare professionals.

The neurogenetic testing market size is expected to see rapid growth in the next few years. It will grow to $1.02 billion in 2028 at a compound annual growth rate (CAGR) of 13.6%. The growth in the forecast period can be attributed to expanding applications in personalized medicine, the rise in chronic diseases, an increased number of hospitals, a growing number of diagnostic laboratories, and a growing demand for early disease detection. Major trends in this period include technological advancements, greater adoption of non-invasive testing methods, new product development, strategic collaborations, and the emergence of novel biomarkers for neurological conditions.

The increase in neurological disorders is expected to drive the growth of the neurogenetic testing market. Neurological disorders encompass conditions affecting the nervous system, including the brain, spinal cord, and nerves. These disorders can arise from genetic predisposition, infections, trauma, toxins, autoimmune responses, or degeneration. Neurogenetic testing plays a crucial role in enhancing the diagnosis, treatment, and management of neurological disorders. It provides personalized insights into genetic risk factors, guides treatment decisions, and empowers patients and families to make informed healthcare choices, thereby improving patient care and outcomes. For example, as reported by the European Brain Council in April 2022, millions globally suffer from over 600 neurological diseases and nearly 300 psychiatric conditions, including 65 million with epilepsy. In Europe, 10.5 million people have dementia, with projections indicating a rise to 18.7 million by 2050. Hence, the increasing prevalence of neurological disorders is expected to fuel the growth of the neurogenetic testing market.

The rising prevalence of cancer is also expected to boost the neurogenetic testing market. Cancer, characterized by uncontrolled cell division and tissue destruction, is on the rise due to factors such as the obesity epidemic, inherited genetic abnormalities, and viral infections such as hepatitis B and C, Epstein-Barr virus (EBV), and human papillomavirus (HPV). Neurogenetic testing is crucial for cancer management as it aids in selecting the most effective treatment, assessing prognoses, identifying high-risk patients, and providing personalized care based on individual genetic profiles and family history. For instance, the American Society of Clinical Oncology reported in May 2024 that an estimated 20 million new cancer cases were identified in 2022, with projections of 35 million new cases globally by 2050, leading to 9.7 million deaths from the disease. Consequently, the increasing prevalence of cancer is propelling the growth of the neurogenetic testing market.

Major companies are focusing on developing innovative products such as whole-genome sequencing to improve genetic analysis accuracy and scope. Whole-genome sequencing (WGS) is a comprehensive genetic testing method that involves determining an individual's entire genome DNA sequence. For instance, Nucleus Genomics, a US-based company specializing in genetic analysis, launched a DNA analysis product in March 2024. This platform provides people with a deeper understanding of their genetic predispositions, enabling informed decisions about health and well-being. Nucleus Genomics aims to redefine genetic testing by offering cutting-edge technology and expert genetic counseling services, making whole-genome sequencing accessible and revolutionizing genomic medicine.

Major companies operating in the neurogenetic testing market are Thermo Fisher Scientific Inc., Mayo Clinic, Roche Diagnostics Corporation, Laboratory Corporation, Quest Diagnostics Incorporated, Eurofins Scientific Inc., Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Exact Sciences Corporation, Myriad Genetics Inc., BioReference Laboratories Inc., Connecticut Children's, Invitae Corp., Ambry Genetics Corporation, Fulgent Genetics Inc., Blueprint Genetics Inc., GeneDx LLC, Pacific Biosciences of California Inc., MedGenome Labs, CENTOGENE, Baylor Genetics, Victorian Clinical Genetics Services

North America was the largest region in the neurogenetic testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurogenetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the neurogenetic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The neurogenetic testing market includes revenues earned by entities by providing services such as diagnostic testing, predictive testing, carrier screening, and prenatal testing and related products such as genetic testing kits, DNA sequencing platforms, and bioinformatics software. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neurogenetic Testing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neurogenetic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neurogenetic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The neurogenetic testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Microarray Analysis; Whole-Exome Sequencing (WES); Multiplex Ligation Dependent Probe Amplification (MLPA); Polymerase Chain Reaction (PCR) Tests; Other Types
  • 2) By Disease: Rare Genetic Disorder; Cancer; Cystic Fibrosis; Sickle Cell Anemia; Duchenne Muscular Dystrophy; Thalassemia; Huntington's Disease; Fragile X Syndrome; Other Diseases
  • 3) By End-Users: Hospitals; Specialty Clinics; Research Institutes; Diagnostics Laboratories
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Mayo Clinic; Roche Diagnostics Corporation; Laboratory Corporation; Quest Diagnostics Incorporated
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Neurogenetic Testing Market Characteristics

3. Neurogenetic Testing Market Trends And Strategies

4. Neurogenetic Testing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Neurogenetic Testing Market Size and Growth

  • 5.1. Global Neurogenetic Testing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Neurogenetic Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Neurogenetic Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Neurogenetic Testing Market Segmentation

  • 6.1. Global Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Microarray Analysis
  • Whole-Exome Sequencing (WES)
  • Multiplex Ligation Dependent Probe Amplification (MLPA)
  • Polymerase Chain Reaction (PCR) Tests
  • Other Types
  • 6.2. Global Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Rare Genetic Disorder
  • Cancer
  • Cystic Fibrosis
  • Sickle Cell Anemia
  • Duchenne Muscular Dystrophy
  • Thalassemia
  • Huntington's Disease
  • Fragile X Syndrome
  • Other Diseases
  • 6.3. Global Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Research Institutes
  • Diagnostics Laboratories

7. Neurogenetic Testing Market Regional And Country Analysis

  • 7.1. Global Neurogenetic Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Neurogenetic Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Neurogenetic Testing Market

  • 8.1. Asia-Pacific Neurogenetic Testing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Neurogenetic Testing Market

  • 9.1. China Neurogenetic Testing Market Overview
  • 9.2. China Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Neurogenetic Testing Market

  • 10.1. India Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Neurogenetic Testing Market

  • 11.1. Japan Neurogenetic Testing Market Overview
  • 11.2. Japan Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Neurogenetic Testing Market

  • 12.1. Australia Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Neurogenetic Testing Market

  • 13.1. Indonesia Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Neurogenetic Testing Market

  • 14.1. South Korea Neurogenetic Testing Market Overview
  • 14.2. South Korea Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Neurogenetic Testing Market

  • 15.1. Western Europe Neurogenetic Testing Market Overview
  • 15.2. Western Europe Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Neurogenetic Testing Market

  • 16.1. UK Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Neurogenetic Testing Market

  • 17.1. Germany Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Neurogenetic Testing Market

  • 18.1. France Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Neurogenetic Testing Market

  • 19.1. Italy Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Neurogenetic Testing Market

  • 20.1. Spain Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Neurogenetic Testing Market

  • 21.1. Eastern Europe Neurogenetic Testing Market Overview
  • 21.2. Eastern Europe Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Neurogenetic Testing Market

  • 22.1. Russia Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Neurogenetic Testing Market

  • 23.1. North America Neurogenetic Testing Market Overview
  • 23.2. North America Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Neurogenetic Testing Market

  • 24.1. USA Neurogenetic Testing Market Overview
  • 24.2. USA Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Neurogenetic Testing Market

  • 25.1. Canada Neurogenetic Testing Market Overview
  • 25.2. Canada Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Neurogenetic Testing Market

  • 26.1. South America Neurogenetic Testing Market Overview
  • 26.2. South America Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Neurogenetic Testing Market

  • 27.1. Brazil Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Neurogenetic Testing Market

  • 28.1. Middle East Neurogenetic Testing Market Overview
  • 28.2. Middle East Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Neurogenetic Testing Market

  • 29.1. Africa Neurogenetic Testing Market Overview
  • 29.2. Africa Neurogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Neurogenetic Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Neurogenetic Testing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Neurogenetic Testing Market Competitive Landscape And Company Profiles

  • 30.1. Neurogenetic Testing Market Competitive Landscape
  • 30.2. Neurogenetic Testing Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Mayo Clinic
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Roche Diagnostics Corporation
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Laboratory Corporation
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Quest Diagnostics Incorporated
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Neurogenetic Testing Market Other Major And Innovative Companies

  • 31.1. Eurofins Scientific Inc.
  • 31.2. Agilent Technologies Inc.
  • 31.3. PerkinElmer Inc.
  • 31.4. Illumina Inc.
  • 31.5. Bio-Rad Laboratories Inc.
  • 31.6. QIAGEN N.V.
  • 31.7. Exact Sciences Corporation
  • 31.8. Myriad Genetics Inc.
  • 31.9. BioReference Laboratories Inc.
  • 31.10. Connecticut Children's
  • 31.11. Invitae Corp.
  • 31.12. Ambry Genetics Corporation
  • 31.13. Fulgent Genetics Inc.
  • 31.14. Blueprint Genetics Inc.
  • 31.15. GeneDx LLC

32. Global Neurogenetic Testing Market Competitive Benchmarking

33. Global Neurogenetic Testing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Neurogenetic Testing Market

35. Neurogenetic Testing Market Future Outlook and Potential Analysis

  • 35.1 Neurogenetic Testing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Neurogenetic Testing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Neurogenetic Testing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer